The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
October 23rd 2024
Alto Neuroscience's ALTO-100 failed to beat placebo in a phase 2b trial for depression, leading to a 60% stock drop.
October 23rd 2024
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Transcranial Magnetic Stimulation (TMS) Clinic Offers Noninvasive Treatment For Major Depression
November 6th 2009Committing to the promise it holds, Rush University Medical Center psychiatrists are now putting into action transcranial magnetic stimulation, the first FDA-approved, non-invasive antidepressant device-based treatment that is clinically proven for depression treatment, making them among the first to test the technique after having helped develop it.
Schizophrenia-related Gene Deletion Alters Brain's Circuit System, Development
October 19th 2009Researchers at the University of North Carolina-Chapel Hill have discovered how the 22q11 gene deletion is associated with changes in brain development that affect how the circuit system in the brain is put together.
Alcohol Use Common Among Chronic Pain Patients
October 6th 2009Professionals should educate and monitor their pain patients' use of alcohol according to a University of Florida study which found that use of alcohol as a pain management strategy was consistent across the three patient groups, ranging from 25 to 28 percent. Use was more prevalent in men and corresponded to higher income levels.
New Schizophrenia Drug Extends Time to Relapse and Treatment Discontinuation
September 21st 2009The results of a new clinical trial of the schizophrenia drug Saphris (asenapine) has shown that the drug is effective at significantly extending both the time to relapse or impending relapse and the time to treatment discontinuation.
Depression Following a Coronary Event Increases Risk of Death
September 16th 2009Patients who suffer from depression in the first several weeks after being hospitalized for a coronary event and those patients whose depression does not improve over six months are at an increased risk of death compared to coronary patients who are not depressed.
Stress in the Workplace may Decrease an Individual's Risk for Developing Rheumatoid Arthritis
September 10th 2009Psychosocial work stress has been previously associated with an increased risk for cardiovascular disease. New research now reveals that high work stress may actually decrease an individual's chance of developing inflammatory conditions, including rheumatoid arthritis.
Majority of Chronic Pain Patients Improperly Use Prescribed Medications
August 27th 2009An Ameritox study found that of 938,586 urine toxicology tests administered to chronic pain patients over a three-year period, 11% detected major illicit drugs and 29% had a medication in their system that the patient's doctor was likely unaware of.